Life Corp
TSE:8194
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (11.6), the stock would be worth ¥2 943.51 (14% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.2 | ¥2 587 |
0%
|
| 3-Year Average | 11.6 | ¥2 943.51 |
+14%
|
| 5-Year Average | 11.6 | ¥2 943.51 |
+14%
|
| Industry Average | 24.8 | ¥6 293.52 |
+143%
|
| Country Average | 22.4 | ¥5 674.06 |
+119%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Life Corp
TSE:8194
|
223.8B JPY | 10.2 | 11.9 | |
| ZA |
S
|
Shoprite Holdings Ltd
JSE:SHP
|
151.8B ZAR | 35.5 | 20 | |
| CA |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
73.8B CAD | 17.4 | 19.4 | |
| CA |
|
Loblaw Companies Ltd
TSX:L
|
73.4B CAD | 28.4 | 27.4 | |
| UK |
|
Tesco PLC
LSE:TSCO
|
32.4B GBP | 28.8 | 18.1 | |
| US |
|
Kroger Co
NYSE:KR
|
43.5B USD | 18 | 43.1 | |
| NL |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
35.5B EUR | 40.5 | 15.7 | |
| IN |
|
Avenue Supermarts Ltd
NSE:DMART
|
3T INR | -390.3 | 103.7 | |
| JP |
|
Seven & i Holdings Co Ltd
TSE:3382
|
5T JPY | -33.2 | 17.1 | |
| US |
|
Caseys General Stores Inc
NASDAQ:CASY
|
30.9B USD | 97.1 | 47.6 | |
| AU |
|
Woolworths Group Ltd
ASX:WOW
|
41.7B AUD | 27.5 | 69.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 14.9 |
| Median | 22.4 |
| 70th Percentile | 35 |
| Max | 736 044 589.7 |
Other Multiples
Life Corp
Glance View
Life Corp began its journey in the early 2000s, emerging from a small start-up to a notable player in the healthcare and wellness sector. Initially focusing on developing innovative medical devices, the company identified a niche in integrated healthcare solutions. It invested heavily in research and technology, establishing partnerships with leading hospitals and clinics to provide state-of-the-art diagnostic equipment. This strategic collaboration not only broadened its market reach but also ensured a steady revenue stream from the leasing and maintenance of its technology. Over the years, Life Corp expanded its portfolio, delving into telemedicine platforms that have become increasingly popular. The company's business model revolves around coupling its hardware offerings with consistent customer support services, creating a robust ecosystem that clients rely on. By streamlining operations through digital solutions, Life Corp has successfully tapped into recurring income. The seamless integration of software with medical applications provides clients with real-time data, optimizing their healthcare management processes. This dual-source income strategy, combining product sales with subscription-based services, has fueled Life Corp’s sustainable growth, enabling it to secure a stable foothold in an ever-evolving industry.